Phase I trial of resokine in volunteers in the European Union.
Phase of Trial: Phase I
Latest Information Update: 21 May 2014
Price : $35 *
At a glance
- Drugs Resokine (Primary)
- Indications Immunodeficiency disorders
- Focus Adverse reactions
- Sponsors aTyr Pharma
- 21 May 2014 Tolerability results were reported in an aTyr Pharma media release.
- 21 May 2014 Status changed from active, no longer recruiting to completed, according to an aTyr Pharma media release.
- 26 Feb 2014 New trial record